Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.
Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Ayav C, Speyer E, Robinson BM, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Collaborators. Laville SM, et al. Among authors: laville m. Br J Clin Pharmacol. 2018 Dec;84(12):2811-2823. doi: 10.1111/bcp.13738. Epub 2018 Sep 24. Br J Clin Pharmacol. 2018. PMID: 30110711 Free PMC article.
Adverse Drug Reactions in Patients with CKD.
Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, Fouque D, Laville M, Frimat L, Robinson BM, Stengel B, Massy ZA, Liabeuf S; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) Study Group. Laville SM, et al. Among authors: laville m. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1090-1102. doi: 10.2215/CJN.01030120. Epub 2020 Jul 1. Clin J Am Soc Nephrol. 2020. PMID: 32611662 Free PMC article.
Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S, Lambert O, Metzger M, Hamroun A, Laville M, Laville SM, Frimat L, Pecoits-Filho R, Fouque D, Massy ZA, Jacquelinet C, Stengel B; Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD REIN) Study Group. Liabeuf S, et al. Among authors: laville sm, laville m. Br J Clin Pharmacol. 2021 Jul;87(7):2967-2976. doi: 10.1111/bcp.14713. Epub 2021 Jan 19. Br J Clin Pharmacol. 2021. PMID: 33368448 Free article.
Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins.
Laville SM, Massy ZA, Kamel S, Chillon JM, Choukroun G, Liabeuf S. Laville SM, et al. Toxins (Basel). 2021 Jan 26;13(2):91. doi: 10.3390/toxins13020091. Toxins (Basel). 2021. PMID: 33530404 Free PMC article. Review.
Consequences of oral antithrombotic use in patients with chronic kidney disease.
Laville SM, Lambert O, Hamroun A, Metzger M, Jacquelinet C, Laville M, Frimat L, Fouque D, Combe C, Ayav C, Pecoits-Filho R, Stengel B, Massy ZA, Liabeuf S; CKD-REIN Study Collaborators. Laville SM, et al. Among authors: laville m. Clin Transl Sci. 2021 Nov;14(6):2242-2253. doi: 10.1111/cts.13084. Epub 2021 Jun 24. Clin Transl Sci. 2021. PMID: 34080321 Free PMC article.
24 results